BridgeBio Pharma, Inc. (BBIO)
74.03
+1.33
(+1.83%)
USD |
NASDAQ |
Dec 11, 16:00
74.03
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Research and Development Expense (TTM): 465.89M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Supernus Pharmaceuticals, Inc. | 104.86M |
| Ionis Pharmaceuticals, Inc. | 879.75M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |